aTyr Pharma Inc LIFE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:14 PM EST
2.28quote price arrow up+0.04 (+1.79%)
Volume
80,026
52 week range
2.00 - 6.62
Loading...
  • Open2.25
  • Day High2.32
  • Day Low2.22
  • Prev Close2.24
  • 52 Week High6.62
  • 52 Week High Date03/23/22
  • 52 Week Low2.00
  • 52 Week Low Date12/22/22

Key Stats

  • Market Cap66.141M
  • Shares Out29.01M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change5.93

KEY STATS

  • Open2.25
  • Day High2.32
  • Day Low2.22
  • Prev Close2.24
  • 52 Week High6.62
  • 52 Week High Date03/23/22
  • 52 Week Low2.00
  • 52 Week Low Date12/22/22
  • Market Cap66.141M
  • Shares Out29.01M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change5.93

RATIOS/PROFITABILITY

  • EPS (TTM)-1.65
  • P/E (TTM)-1.38
  • Fwd P/E (NTM)-1.04
  • EBITDA (TTM)-46.793M
  • ROE (TTM)-47.61%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,468.63%
  • Debt To Equity (MRQ)1.01%

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On aTyr Pharma Inc

 

Content From Our Affiliates

Profile

MORE
aTyr Pharma, Inc. is a biotherapeutics company engaged in the discovery and development of medicines based on novel biological pathways. Its therapeutic candidate pipeline includes efzofitimod (ATYR1923), ATYR2810, NRP2 mAbs, AARS-1 and DARS-1. The ATYR1923, is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable (Fc) region of a human antibody and serves as a selective modulator of NRP2 that downregulates...
John Clarke
Independent Chairman of the Board
Sanjay Shukla M.D.
President, Chief Executive Officer, Director
Jill Broadfoot
Chief Financial Officer
Nancy Denyes J.D.
General Counsel, Corporate Secretary
Address
3545 John Hopkins Ct Ste 250
San Diego, CA
92121-1115
United States

Top Peers

SYMBOLLASTCHG%CHG
SPRB
Spruce Biosciences Inc
3.01-0.03-0.99%
IMUX
Immunic Inc
2.76+0.19+7.39%
JSPR
Jasper Therapeutics Inc
1.96+0.18+9.83%
ADVM
Adverum Biotechnologies Inc
0.7198+0.0209+2.9904%
ANEB
Anebulo Pharmaceuticals Inc
2.88-0.11-3.51%